CALGARY, Alberta–(BUSINESS WIRE)–Today, Orpyx® Medical Technologies Inc. (Orpyx) announced the addition of Dr. David Shulkin, the Ninth Secretary of the U.S. Department of Veterans Affairs (VA), to its advisory board. Secretary Shulkin brings unmatched expertise in policy, operations, and innovation adoption within the VA and across U.S. healthcare systems.
The Department of Veterans Affairs (VA) is one of the largest integrated health systems in the world, uniquely positioned to improve the lives of Veterans with its multidisciplinary Prevention of Amputations In Veterans Everywhere (PAVE) program. According to Veteran Health Administration (VHA) data, there are over 1.6 million Veterans with diabetes receiving care within the VHA. In fiscal year 2024, VHA treated over 49,000 diabetic foot ulcers (DFUs). Of those who develop an ulcer, 15% will require amputation. Preventive measures are crucial and can save VHA roughly $50,000 in direct medical costs per prevented amputation.
“Preventing diabetic foot ulcers and amputations is not only a critical medical priority but also a major economic imperative,” said Secretary David Shulkin. “Orpyx’s technology directly supports the VA’s mission to improve Veteran health outcomes, advance value-based care, and reduce the substantial costs associated with diabetes-related complications.”
“Secretary Shulkin is a nationally recognized healthcare policy leader at the forefront of value-based care and chronic disease prevention,” said Breanne Everett, CEO and founder of Orpyx. “His strategic insights will help us rapidly scale across the VA and other major payer networks, advancing our shared mission to reduce diabetes-related foot complications — a challenge that drives more than $80 billion in annual healthcare spending. Together, we can change that trajectory.”
Dr. Shulkin’s appointment underscores Orpyx’s leadership in digital health and strengthens its ability to scale preventive care solutions nationwide.
About Orpyx Medical Technologies Inc.
Orpyx® is a health technology company helping people with diabetes stay on their feet and preserve independence through its patented sensor-enabled smart insole system and integrated remote care program. Built to detect early warning signs and prompt timely intervention, the Orpyx solution helps improve adherence, reduce total costs, and preserve mobility and quality of life. The company partners with VA Medical Centers, health systems, and payers across North America to deliver clinically validated outcomes and cost savings at scale.
Contacts
Media Inquiries:
Karen Smith
SVP, Marketing & Strategic Market Access
[email protected]
210-823-9604
www.orpyx.com
